chr1-16987187-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 2P and 10B. PM2BP4_ModerateBP6_Very_Strong
The NM_022089.4(ATP13A2):c.2942C>T(p.Thr981Met) variant causes a missense change. The variant allele was found at a frequency of 0.000138 in 1,613,714 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T981T) has been classified as Likely benign.
Frequency
Consequence
NM_022089.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATP13A2 | NM_022089.4 | c.2942C>T | p.Thr981Met | missense_variant | 26/29 | ENST00000326735.13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATP13A2 | ENST00000326735.13 | c.2942C>T | p.Thr981Met | missense_variant | 26/29 | 1 | NM_022089.4 | A1 | |
ENST00000446261.1 | n.187+8075G>A | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000664 AC: 101AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000200 AC: 50AN: 249428Hom.: 0 AF XY: 0.000148 AC XY: 20AN XY: 135168
GnomAD4 exome AF: 0.0000828 AC: 121AN: 1461400Hom.: 0 Cov.: 36 AF XY: 0.0000757 AC XY: 55AN XY: 727018
GnomAD4 genome AF: 0.000663 AC: 101AN: 152314Hom.: 0 Cov.: 33 AF XY: 0.000618 AC XY: 46AN XY: 74470
ClinVar
Submissions by phenotype
Kufor-Rakeb syndrome;C5567893:Autosomal recessive spastic paraplegia type 78 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 08, 2024 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 14, 2022 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at